Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients

Fig. 1

TTK expression across cancers. (A) TTK mRNA is upregulated in 18/33 cancer types versus normal tissues; (B) TIMER analysis showing upregulated TTK mRNA in 21/33 cancer; (C) TTK mRNA expression across cancers in the GEPIA cohort; ns = not significant; ACC, adrenocortical carcinoma; BLCA, bladder cancer; BRCA, breast cancer; CESC, cervical cancer; CHOL, cholangiocarcinoma; COAD, colon cancer; ESCA, oesophageal cancer; GBM, glioblastoma; HNSC, head and neck cancer; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LIHC, liver cancer; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; PRAD, prostate cancer; READ, rectum cancer; STAD, stomach cancer; THCA, thyroid cancer; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma; UVM, uveal melanoma; ***P < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us